India virus infections at three-week high, Mumbai hires marshals to enforce mask-wearing

NEW DELHI (Reuters) – India reported on Friday its biggest jump in new coronavirus infections in three weeks, with 13,193 cases, while thousands of marshals fanned out to enforce mask wearing across the financial capital of Mumbai, which is battling a recent spurt.

The tally of confirmed infections is 10.96 million, the second highest after the United States, with more than 156,000 deaths. But actual infections could range as high as 300 million, a government serological survey showed this month.

In recent days, 75% of India’s new cases have been reported from the southern state of Kerala and Maharashtra, home to Mumbai, a densely populated city of 20 million people. The two states already had the highest number of reported infections.

Health experts suggest the re-opening of educational institutes in Kerala and resumption of suburban train services in Mumbai could be key factors.

After a gap of 11 months, Mumbai resumed on Feb. 1 full suburban train services, which before the pandemic carried a daily average of 8 million people.

The city has begun hiring marshals to enforce mask wearing. Out of nearly 5,000 marshals, around 300 would be deployed on the rail network, city authorities said.

Indians have largely given up on masks and social distancing, Reuters reporting shows.

“Coronavirus … has not yet left the country,” the health ministry said on Twitter. “We still need to follow COVID-appropriate behavior. No carelessness till there is a cure.”

Despite the recent rise in infections, India’s daily tally of new cases remains well below a mid-September peak of nearly 100,000. Testing numbers have also fallen to about 800,000 a day from more than 1 million.

Since starting its vaccine campaign in mid-January, India has administered nearly 10 million doses, aiming to cover 300 million people by August.

(Reporting by Krishna N. Das and Anuron Kumar Mitra; Editing by Simon Cameron-Moore)

Exclusive: UK auditing Indian vaccine site amid scramble for shots-sources

By Neha Arora, Krishna N. Das and Euan Rocha

NEW DELHI (Reuters) – Britain’s drug regulator is auditing manufacturing processes at Serum Institute of India (SII) which could pave the way for AstraZeneca’s COVID-19 vaccine to be shipped from there to the UK and other countries, according to two sources close to the matter.

SII, the world’s largest vaccine manufacturer, is currently mass producing the AstraZeneca vaccine, developed in conjunction with Oxford University, for dozens of poor and middle-income countries but not the UK, which has been getting its supply of the shot primarily from domestic facilities.

If the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) gives SII’s manufacturing process for the Oxford/AstraZeneca shot a greenlight it would allow the drug to be exported to the UK and to other countries which recognize MHRA’s clearances, one of the sources said.

Reuters could not determine what was the rationale for the audit. SII did not respond to a request for comment on it. The MHRA confirmed that an inspection was happening but declined further comment.

“Due to commercial confidentiality we do not comment on inspections that are still ongoing,” the regulator’s chief executive Dr. June Raine said in a statement to Reuters.

The two sources, who asked not to be named as the matter is private, said the audit should be relatively routine for SII, as its site already supplies other vaccines to the UK.

The inspection comes as countries around the world scramble to secure vaccine supplies amid supply disruptions and delivery cuts from leading drugmakers such as Pfizer Inc, Moderna and AstraZeneca.

It was not immediately clear whether an MHRA approval would allow the UK or AstraZeneca to route SII volumes of COVISHIELD – the brand name under which SII markets the AstraZeneca shot – to the EU, which has been pressuring the UK for supply from AstraZeneca’s facilities in the UK, amid shortages in Europe.

AstraZeneca executives told EU officials last week that to accelerate supplies to the bloc, it could provide it with some doses manufactured outside Europe, two EU sources told Reuters. One said the SII could be a supplier.

AstraZeneca, which has previously tapped SII to help fulfill some of its vaccine orders from Brazil, South Africa and Saudi Arabia, did not respond to a request for comment on whether it needs SII to help meet commitments in the UK, or in any other nations that would recognize an MHRA certification.

It was not immediately available to comment on the reported offer to supply the EU with shots from the SII.

INSPECTIONS

The EU’s drug regulator, the European Medicines Agency (EMA), audits sites from which it plans to source medicines but during the global pandemic, with multiple COVID-19 vaccines being developed, it is also partly leaning on inspections carried out by some other international regulators.

“Inspection outcomes for Covid-19 vaccines conducted by the MHRA will be considered by EMA,” said the regulator. Any such approved sites would also need an EMA sign off before they can export to the EU, the regulator told Reuters.

MHRA declined to comment on specifics, but Raine said it was collaborating “with international partners in response to the global pandemic and on matters of mutual interest.”

The UK has expressed an interest in purchasing vaccines from SII, according to the second source, along with a government official in New Delhi. The two sources said the volumes or timelines for any such purchases were unclear.

A UK government spokeswoman said: “Any discussions that have taken place between the UK Government and India on vaccines are not related to securing extra vaccine supply to the UK.”

The UK has so far ordered 100 million doses of AstraZeneca’s vaccine.

“Most countries have approached us and India’s government,” SII told Reuters, but it did not comment on any UK outreach. “We are trying our best to meet demand, and supply the vaccine to as many countries as possible, keeping India as the priority.”

SII’s chief executive, Adar Poonawalla, told Reuters in late January, his family-owned firm was keen to support AstraZeneca’s supply needs but its primary focus was on India and other poorer nations in Asia and Africa. He said at the time SII had no plans to divert supplies to Europe.

(Neha Arora and Krishna N.Das reported from New Delhi and Euan Rocha reported from Mumbai; Additional reporting by Paul Sandle, Kate Kelland and Alistair Smout in London, Francesco Guarascio in Brussels and Ludwig Burger in Frankfurt; Editing by Carmel Crimmins)

Tajikistan quake shakes north India, Pakistan, no major damage

By Neha Arora

NEW DELHI (Reuters) – A strong earthquake struck Tajikistan on Friday and the tremors were felt as far away as north India and Pakistan, witnesses said. Many residents ran out of their homes, but no major damage was reported.

The U.S Geological Survey put the quake’s magnitude at 5.9 and centered 35 km (55 miles) west of Murghob in Tajikistan, central Asia.

The Tajikistan Emergency Situations Ministry said the epicenter was 420 km (260 miles) east of the Tajik capital Dushanbe near the border with China.

The seismic service of the country’s Academy of Sciences told Russia’s RIA Novosti that the quake’s intensity was measured at 6.1. The news agency said there were no casualties or damage, citing the Committee on Emergency Situations.

Monitoring agencies in the region pegged the quake as being a bit more severe. India’s National Center for Seismology said its magnitude was 6.3, while the National Seismic Monitoring Center in Pakistan measured it at 6.4.

Tremors were felt in Dushanbe but the epicenter was in a sparsely populated area.

Cracks were reported in some homes in northern Kashmir, the Indian Meteorological Department said. A witness also reported a wall collapse near the northern Indian city of Amritsar, but there were no reports of casualties.

A resident in Indian Kashmir’s Baramulla district said it felt like a strong wind had lashed his house. “My whole house shook and cracks appeared in a corner of one of the rooms,” Firdous Ahmad Khan said.

Tremors were felt across Pakistan including the capital, Islamabad, and northwestern Peshawar, and even as far as the eastern city of Lahore, which borders India.

In Muzaffarabad, the capital of Pakistani Kashmir, where a 2005 earthquake wreaked serious destruction, there was panic, according to witnesses, and many people rushed out of their homes in fear.

“I thought it’s the same like what had hit us in 2005. My children started crying,” said Asif Maqbool, a resident in Madina Market, a neighborhood of Muzaffarabad that was almost flattened in the 2005 quake.

Saima Khalid, a resident of the Khawaja Muhalla district of Muzaffarabad, said everyone in the neighborhood came out onto the streets.

The quake was also felt in northern Afghanistan but there were no reports of casualties or damage.

(Additional reporting by Andrew Osborn in Moscow, Nazarali Pirnazarov in Tajikistan Fayaz Bukari in Srinagar, Rupam Jain, Charlotte Greenfield and Umar Farooq in Islamabad, Jibran Ahmad in Peshawar, Abu Arqam Naqash in Muzaffarabad, Mubasher Bukhari in Lahore ; Editing by Sanjeev Miglani and Giles Elgood)

Rising waters in Indian Himalayas disrupt rescue bid in tunnel after avalanche

By Alasdair Pal and Neha Arora

TAPOVAN, India (Reuters) – Authorities in India warned on Thursday of rising water levels in a Himalayan river valley hit by a major avalanche as they scaled back a search for 35 construction workers trapped in a flooded tunnel.

Rescue workers have found the bodies of 36 people since Sunday’s avalanche that tore through dams and swept away bridges in the Dhauliganga river valley of Uttarakhand state.

Some 171 people remain unaccounted for, most of them workers at the state-run Tapovan Vishnugad hydroelectric project and at the smaller Rishiganga dam, which was swept away by the avalanche-driven torrent.

An official with the National Disaster Response Force (NDRF) said the number of rescue teams were limited at the tunnel site after river water levels began to surge.

“There was an input from a village that the river upstream was swelling so we sounded an alert. The rescue mission was stopped for about 30 minutes,” Swati Bhadoriya, Chamoli District Magistrate, told Reuters.

Relief workers have been drilling inside a 2.5-km-long tunnel connected to the Tapovan project, where slush and water has been so heavy that soldiers have made only halting progress in four days.

Experts have cautioned there could be still be huge amounts of rock, debris, ice and water that could get released due to changes in temperatures.

“Snow melt or rain could trigger a debris flow at any moment, probably not of the size of the event on Sunday, but critical for anybody and anything close to the river,” said Holger Frey, a senior scientist with the Glaciology and Geomorphodynamics Group (3G) in the geography faculty at the University of Zurich.

RESCUE EFFORTS, DISTRAUGHT FAMILIES

After clearing more than 100 meters of mud, rocks and debris, relief workers on Thursday sent water tankers and generators deep into the tunnel to assist in drilling.

They were searching for signs of life in smaller tunnels and rooms branching off from the main passage, officials said.

Relatives continued to arrive at the site, but five days after the disaster, frustration at the lack of progress mounted.

“They are not telling us anything,” said Praveen Saini, whose nephew, Ajay Kumar Saini, is trapped in the tunnel.

Another man was clinging to hope that his brother had survived after he was able to ring his mobile phone. “If his phone survived, maybe he survived,” Jugal Kishore said.

Originally thought to be a glacier breaking apart in India’s second highest mountain Nanda Devi and crashing into the river, some scientists now say the flood was more likely to have been caused by an avalanche.

“It appears that the event was caused by a very large rockfall from high up the mountainside which picked up lots of snow and ice on the way down and melted these because of the frictional heat created by the rock fall,” said Stephan Harrison, professor of Climate and Environmental Change at the University of Exeter in Britain.

(Additional reporting by Saurabh Sharma and Neha Arora; Writing by Neha Arora; Editing by Sanjeev Miglani and Mark Heinrich)

In Indian Himalayas, drones draw blank in search for workers missing in flooded tunnel

By Alasdair Pal and Neha Arora

TAPOVAN, India (Reuters) – Rescuers in northern India made a vain attempt on Wednesday to find signs of life using a drone to search for 35 construction workers missing inside a tunnel days after a flash flood swept down a mountain valley destroying dams and bridges.

Some 204 people remain unaccounted for since Sunday’s disaster in Uttarakhand state, most of them workers at the Tapovan Vishnugad hydroelectric project and at the smaller Rishiganga dam, which was swept away by the torrent.

At the Tapovan tunnel’s entrance, anxious relatives lingered in heavy rain, desperate for word on whether anyone had been found.

“We don’t know what else to do,” said Deepa Chauhan the sister of 30-year-old Patminder Bisht, a supervisor among the workers at the site.

A drone with five cameras was sent inside a short stretch of the tunnel for a second day on Wednesday, but found no-one, either alive or dead, an official said.

So far, police say, 32 bodies have been retrieved from the Himalayan mountainsides or pulled out of the Dhauliganga river further downstream.

As the hours passed in the winter cold, there was a mounting risk hypothermia could kill anyone in the tunnel who had survived, said Vivek Pandey, a spokesman for the Indo-Tibetan Border Police, a paramilitary force involved in the rescue effort.

Excavators had cleared more than 80 meters of mud blocking the tunnel entrance, but still have at least another 80 meters to go to reach where most of the workers were believed to be trapped, officials at the site said.

Giant boulders were blocking progress.

“Sediment and water has entered the tunnel and we are unable to clear it,” a government official monitoring the situation from New Delhi told Reuters.

Elsewhere in the valley, helicopters dropped food parcels and villagers set up a zip wire across the river to deliver supplies to some of the 13 mountain villages cut off by the disaster.

A team of scientists have reached the glacier site to determine what triggered a calamity, which fueled concern about the building of hydropower projects in the ecologically sensitive mountains.

The flash flood was initially thought to have been caused by a glacier breaking apart and crashing into the river, but some scientists now say it was more likely to have been due to an avalanche.

(Additional reporting by Saurabh Sharma in Lucknow; Writing by Sanjeev Miglani; Editing by Simon Cameron-Moore)

India glacier avalanche leaves 18 dead, more than 200 missing

By Saurabh Sharma

LUCKNOW, India (Reuters) – Rescuers searched for more than 200 people missing in the Indian Himalayas on Monday, including some trapped in a tunnel, after part of a glacier broke away, sending a torrent of water, rock and dust down a mountain valley.

Sunday’s violent surge below Nanda Devi, India’s second-highest peak, swept away the small Rishiganga hydro electric project and damaged a bigger one further down the Dhauliganga river being built by state firm NTPC.

Eighteen bodies have been recovered from the mountainsides, officials said.

Most of the missing were people working on the two projects, part of the many the government has been building deep in the mountains of Uttarakhand state as part of a development push.

“As of now, around 203 people are missing,” state chief minister Trivendra Singh Rawat said, and the number was changing as more information about people caught up by the deluge emerged from the remote area.

Videos on social media showed water surging through a small dam site, washing away construction equipment and bringing down small bridges.

“Everything was swept away, people, cattle and trees,” Sangram Singh Rawat, a former village council member of Raini, the site closest to the Rishiganga project, told local media.

It was not immediately clear what caused the glacier burst on a bright Sunday morning. Experts said it had snowed heavily last week in the Nanda Devi area and it was possible that some of the snow started melting and may have led to an avalanche.

Rescue squads were focused on drilling their way through a 2.5 km (1.5 miles) long tunnel at the Tapovan Vishnugad hydropower project site that NTPC was building 5 km (3 miles) downstream where about 30 workers were believed trapped.

“We are trying to break open the tunnel, it’s a long one, about 2.5 km,” said Ashok Kumar, the state police chief. He said rescuers had gone 150 meters (yards) into the tunnel but debris and slush were slowing progress.

There had been no voice contact yet with anyone in the tunnel, another official said. Heavy equipment has been employed and a dog squad flown to the site to locate survivors.

On Sunday, 12 people were rescued from another much smaller tunnel.

TRIGGER FOR GLACIER BURST

Uttarakhand is prone to flash floods and landslides and the disaster prompted calls by environment groups for a review of power projects in the ecologically sensitive mountains. In June 2013, record monsoon rains there caused devastating floods that claimed close to 6,000 lives.

A team of scientists were flown over the site of the latest accident on Monday to find out what exactly happened.

“It’s a very rare incident for a glacial burst to happen. Satellite and Google Earth images do not show a glacial lake near the region, but there’s a possibility that there may be a water pocket in the region,” said Mohd Farooq Azam, assistant professor, glaciology & hydrology at the Indian Institute of Technology in Indore.

Water pockets are lakes inside the glaciers, which may have erupted leading to this event. Environmental groups have blamed construction activity in the mountains.

Himanshu Thakkar, coordinator of the South Asia Network of Dams, Rivers and People, said that there were clear government recommendations against the use of explosives for construction purposes. “There have been violations.”

The latest accident had also raised questions about the safety of the dams. “The dams are supposed to withstand much greater force. This was not a monsoon flood, it was much smaller.”

(Additional reporting by Nivedita Bhattachargee and Neha Arora; Writing by Sanjeev Miglani; Editing by Michael Perry, Raju Gopalakrishnan and Giles Elgood)

Global COVID-19 cases surpass 100 million as nations tackle vaccine shortages

By Shaina Ahluwalia and Roshan Abraham

(Reuters) – Global coronavirus cases surpassed 100 million on Wednesday, according to a Reuters tally, as countries around the world struggle with new virus variants and vaccine shortfalls.

Almost 1.3% of the world’s population has now been infected with COVID-19, the disease caused by the novel coronavirus, and more than 2.1 million people have died.

One person has been infected every 7.7 seconds, on average, since the start of the year. Around 668,250 cases have been reported each day over the same period, and the global fatality rate stands at 2.15%.

The worst-affected countries – the United States, India, Brazil, Russia and the United Kingdom – make up more than half all reported COVID-19 cases but represent 28% of the global population, according to a Reuters analysis.

It took the world 11 months to record the first 50 million cases of the pandemic, compared to just three months for cases to double to 100 million.

Around 56 countries have begun vaccinating people for the coronavirus, administering at least 64 million doses. Israel leads the world on per capita vaccinations, inoculating 29% of its population with at least one dose.

UNITED STATES

With over 25 million cases, the United States has 25% of all reported COVID cases although it accounts for just 4% of the world’s population. The United States leads the world in the daily average number of new deaths reported, accounting for one in every five deaths reported worldwide each day. With just under 425,00 fatalities, the United States has reported almost twice as many deaths as Brazil, which has the second-highest death toll in the world.

As the worst-affected region in the world, Europe is currently reporting a million new infections about every four days and has reported nearly 30 million since the pandemic began. Britain on Tuesday reached 100,000 deaths.

The Eastern European region, including countries like Russia, Poland and Ukraine, contribute to nearly 10% of all global COVID-19 cases.

Despite securing deals for vaccine supplies early on, many European countries are facing delays in shipments from both Pfizer Inc and AstraZeneca Plc.

ASIA AND AFRICA

In India, the nation with the second-highest number of cases, infections are decreasing, with almost 13,700 new infections reported on average each day – around 15% of its peak. Prime Minister Narendra Modi said on Friday India was completely self-reliant on coronavirus vaccine supplies as the world’s second-most populous country inoculated more than 1 million people within a week of starting its campaign.

China, which recently marked the first anniversary of the world’s first coronavirus lockdown in the central city of Wuhan, is facing its worst wave of local cases since March last year.

As richer nations race ahead with mass vaccination campaigns, Africa is still scrambling to secure supplies as it grapples with concerns about more-infectious variants of the virus first identified in South Africa and Britain.

According to the Reuters tally, African countries have nearly 3.5 million cases and over 85,000 deaths.

The South African variant, also known as 501Y.V2, is 50% more infectious and has been detected in at least 20 countries.

U.S. President Joe Biden will impose a ban on most non-U.S. citizens entering the country who have recently been in South Africa starting Saturday in a bid to contain the spread of a new variant of COVID-19.

Australia and New Zealand have fared better than most other developed economies during the pandemic through swift border closures, lockdowns, strict hotel quarantine for travelers and widespread testing and social distancing.

“We have the virus under control here in Australia, but we want to roll out the vaccine,” Australian Treasurer Josh Frydenberg told a news conference on Sunday.

(Reporting by Shaina Ahluwalia and Roshan Abraham in Bengaluru; Editing by Lisa Shumaker and Jane Wardell)

Indian govt offers to suspend farm reforms; farmers may call off protests

By Mayank Bhardwaj

NEW DELHI (Reuters) – India’s government on Wednesday offered to suspend implementation of three new farm laws that have triggered the biggest farmers’ protests in years, which farm union leaders said they would now consider calling off.

The cornerstone of the reform, introduced in September, allows private buyers to deal directly with farmers.

Angry farmers, who say that will make India’s traditional wholesale markets irrelevant and leave them at the mercy of big retailers and food processors, have camped out on major highways outside New Delhi for more than two months.

Agriculture & Farmers Welfare Minister Narendra Singh Tomar said the government was open to suspending the laws for up to 18 months, during which time representatives of the government and farmers should work to “provide solutions” for the industry.

Bilateral talks have so far failed to break the deadlock – landing Prime Minister Narendra Modi with one of his most significant challenges since he was re-elected in 2019.

The next round of talks is due on Friday, and farm leader Dharmendra Malik said the unions would let the government know then if they would accept the offer and call off the protests.

The government was “sympathetic to farmers’ concerns and is trying to end the stalemate,” it said in a government, thanking them for maintaining “peace and discipline” during the protests.

Farmers plan a tractor rally through New Delhi on Jan 26, India’s Republic Day, which the Supreme Court on Wednesday declined a government petition to ban.

(Reporting by Mayank Bhardwaj; additional reporting by Suchitra Mohanty and Nigam Prusty; editing by John Stonestreet)

U.S. crosses 10 million COVID-19 cases as third wave of infections surges

By Anurag Maan and Shaina Ahluwalia

(Reuters) – The United States became the first nation worldwide since the pandemic began to surpass 10 million coronavirus infections, according to a Reuters tally on Sunday, as the third wave of the COVID-19 virus surges across the nation.

The grim milestone came on the same day as global coronavirus cases exceeded 50 million.

The United states has reported about a million cases in the past 10 days, the highest rate of infections since the nation reported its first novel coronavirus case in Washington state 293 days ago.

The country reported a record 131,420 COVID-19 cases on Saturday and has reported over 100,000 infections five times in the past seven days, according to a Reuters tally.

The U.S. latest reported seven-day average of 105,600 daily cases, ramped up by at least 29%, is more than the combined average for India and France, two of the worst affected countries in Asia and Europe.

More than 237,000 Americans have died of COVID-19 since the illness caused by the coronavirus first emerged in China late last year.

The daily average of reported new deaths in the United States account for one in every 11 deaths reported worldwide each day, according to a Reuters analysis.

The number of reported deaths nationwide climbed by more than 1,000 for a fifth consecutive day on Saturday, a trend last seen in mid-August, according to a Reuters tally.

Health experts say deaths tend to increase four to six weeks after a surge in infections.

U.S. President-elect Joe Biden, who spent much of his election campaign criticizing President Donald Trump’s handling of the pandemic, pledged on Saturday to make tackling the pandemic a top priority.

Biden will announce a 12-member task force on Monday to deal with the pandemic that will be led by former surgeon general Vivek Murthy and former Food and Drug Administration commissioner David Kessler. The coronavirus task force will be charged with developing a blueprint for containing the disease once Biden takes office in January.

The Midwest remains the hardest-hit region based on the most cases per capita with North Dakota, South Dakota, Wisconsin, Iowa and Nebraska the top five worst-affected U.S. states.

Illinois emerged as the new epicenter in the Midwest, with the state reporting over 60,000 COVID-19 infections in the last seven days, the highest in the country, according to Reuters data. The state reported more than 12,454 new cases on Saturday, the highest single-day number so far.

Texas, which accounts for 10% of total U.S. cases, is the hardest-hit state and became the first to surpass a million coronavirus cases in the United States on Saturday.

According to a Reuters analysis, the South region comprises nearly 43% of all the cases in the United States since the pandemic began, with nearly 4.3 million cases in the region alone, followed by the Midwest, West and Northeast.

New York, with over 33,000 fatalities, remains the state with highest number of deaths and accounts for about 14% of total U.S. deaths.

The United States performed about 10.5 million coronavirus tests in the first seven days of November, of which 6.22% came back positive, compared with 6.17% the prior seven-days, according to data from The COVID Tracking Project, a volunteer-run effort to track the outbreak.

(Reporting by Anurag Maan and Shaina Ahluwalia in Bengaluru; Editing by Diane Craft and Michael Perry)

India sees early vaccine launch as AstraZeneca deliveries run late

By Krishna N. Das

NEW DELHI (Reuters) – India raced ahead with work on its coronavirus vaccine while Britain’s AstraZeneca said its deliveries were running “a little bit late” as countries around the world sought to conquer the pandemic and rescue their economies.

A vaccine is seen as the world’s best bet for taming a virus that has infected more than 48 million people, led to more than 1.2 million deaths, roiled economies and disrupted billions of lives since it was first identified in China in December.

Australia is beefing up its prospective arsenal against the pandemic to 135 million doses of various vaccine candidates.

“We aren’t putting all our eggs in one basket,” Prime Minister Scott Morrison said on Thursday.

Some 45 vaccine candidates are in human trials worldwide, with Pfizer Inc saying it could file in late November for U.S. authorization, opening up the possibility of a vaccine being available in the United States by the end of the year.

Moderna and AstraZeneca are close behind the largest U.S. drugmaker and are likely to have early data on their vaccine candidates before the end of the year.

An Indian government-backed vaccine could be launched as early as February – months earlier than expected – as last-stage trials begin this month and studies have so far showed it is safe and effective, a senior government scientist told Reuters.

Bharat Biotech, a private company that is developing COVAXIN with the government-run Indian Council of Medical Research (ICMR), had earlier hoped to launch it only in the second quarter of next year.

“The vaccine has shown good efficacy,” senior ICMR scientist Rajni Kant, who is also a member of its COVID-19 task force, said at the research body’s New Delhi headquarters.

“It is expected that by the beginning of next year, February or March, something would be available.”

Bharat Biotech could not immediately be contacted.

A launch in February would make COVAXIN the first India-made vaccine to be rolled out.

VACCINE KEPT FROZEN

AstraZeneca has signed multiple deals to supply more than three billion doses of its candidate to countries around the world.

But a summer dip in British coronavirus infections had pushed back test results, leading the drugmaker to delay deliveries of shots to the government.

Britain’s vaccines chief said on Wednesday it would receive just 4 million doses of the potential vaccine this year, against initial estimates for 30 million by Sept. 30.

AstraZeneca said on Thursday it was holding back deliveries while it awaits the data from late-stage clinical trials in order to maximize the shelf-life of supplies.

“We are a little bit late in deliveries, which is why the vaccine has been kept in frozen form,” CEO Pascal Soriot said on a conference call.

AstraZeneca and its partner on the project, the University of Oxford, said that data from late-stage trials should land this year.

The United States leads the world in both the number of COVID deaths and infections and the pandemic was a polarizing issue in Tuesday’s presidential election in which votes were still being counted.

Australia’s Morrison said the government would buy 40 million vaccine doses from Novavax and 10 million from Pfizer and BioNTech.

That adds to the 85 million doses Australia has already committed to buy from AstraZeneca and CSL Ltd should trials prove successful.

Among other vaccine candidates around the world, a growing number of Russians are unwilling to be inoculated once a vaccine becomes widely available, the Levada Centre, Russia’s only major independent pollster, said this week.

Russia, raising eyebrows in the West, is rolling out its “Sputnik V” vaccine for domestic use despite the fact that late-stage trials have not yet finished.

(Reporting by Reuters bureaus; Writing by Nick Macfie; Editing by Angus MacSwan)